- ►diabetesjournals.org A Tsang, DJ Hausenloy, MM Mocanu, RD Carr, DM … - Diabetes, 2005 - Am Diabetes Assoc Conflicting evidence exists whether diabetic myocardium can be protected by ischemic preconditioning
(IPC). The phosphatidylinositol 3-kinase (PI3K)-Akt pathway is important in IPC. However, components
of this cascade have been found to be defective in diabetes. We hypothesize that IPC in ... Related articles - All 3 versions
- ►endojournals.org TL Steiler, D Galuska, Y Leng, AV Chibalin, M Gilbert, … - Endocrinology, 2003 - Endocrine Soc We determined basal and insulin-stimulated responses on signaling intermediates in soleus
skeletal muscle from male Wistar and diabetic Goto-Kakizaki (GK) rats. Rats were infused with
glucose (5 or 20 mM) for 3 h, followed by a continuous infusion of saline or insulin (3 ... Cited by 18 - Related articles - BL Direct - All 4 versions
- ►nagasaki-u.ac.jp [PDF] S Matsumoto, S Cho, S Tosaka, H Ureshino, T … - … Drugs and Therapy, 2009 - Springer Abstract Purpose The authors examined whether olprinone, a phosphodiesterase type 3
inhibitor, or isoflurane, a volatile anesthetic, could protect the heart against myocardial infarction
in type 2 diabetic rats and whether the underlying mechanisms involve protein kinase C ( ... Related articles - All 4 versions
V Sivaraman, DJ Hausenloy, AM Wynne, … - Journal of Cellular …, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles - All 2 versions
DJ Hausenloy, DM Yellon - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com Despite optimal therapy, the morbidity and mortality of coronary heart disease (CHD) remains
significant, particularly in patients with diabetes or the metabolic syndrome. New strategies for
cardioprotection are therefore required to improve the clinical outcomes in patients with ... Cited by 5 - Related articles - All 2 versions
M Chikara, K OGAWA, H TAKATSUKA, R ANZAWA, I … - Jikeikai Med J, 2006 - ir.jikei.ac.jp Ischemicheart diseaseis significantlymoreprev- alent and more severe in patients with diabetes
mel- litusthaninthenondiabeticpopulation . However, someanimalstudiessuggest that diabeticheartshave
greater resistanceto ischemia,although other studies suggest they have lower resistance . ... Related articles
HF del Valle, EC Lascano, JA Negroni, AJ … - Molecular and cellular …, 2003 - Springer Sarcolemmal ATP-sensitive potassium (KATP) channels have been mentioned to participate
in preconditioning protection. Since these channels are altered in diabetes, it would be possible
that preconditioning does not develop in diabetic (D) hearts. The purpose of this study ... Cited by 22 - Related articles - BL Direct - All 4 versions
T Ravingerova, R Stetka, D Pancza, O Ulicna, A … - PHYSIOLOGICAL …, 2000 - biomed.cas.cz 608 Ravingerová et al. Vol. 49 cardiomyopathy that has been described in various clinical and
experimental settings (Fein et al. 1980, Dhalla et al. 1985, Dubrey et al. 1994). Contractile dysfunction
as well as rhythm disorders are caused by alterations in the cell membrane ion transport ... Cited by 23 - Related articles - BL Direct - All 4 versions
E Nieszner, I Posa, E Kocsis, G Pogatsa, I … - Experimental and …, 2002 - thieme-connect.com In vivo studies were made in alloxan diabetic and non-diabetic control rabbits to assess if the
effects of preconditioning and sulfonylurea pretreatment with either glibenclamide or glimepiride
(0.05-0.2-0.6 ?mol kg -1 ) influence the extent of the infarcted area caused by one hour ... Cited by 24 - Related articles - BL Direct - All 4 versions
